{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T22:30:45Z","timestamp":1791844245417,"version":"4.3.4"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2018,9,4]],"date-time":"2018-09-04T00:00:00Z","timestamp":1536019200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Drugs"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1007\/s40272-018-0314-0","type":"journal-article","created":{"date-parts":[[2018,9,4]],"date-time":"2018-09-04T05:27:24Z","timestamp":1536038844000},"page":"575-583","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["The Effect of Alginate in Gastroesophageal Reflux in Infants"],"prefix":"10.1007","volume":"20","author":[{"given":"Silvia","family":"Salvatore","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Ripepi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koen","family":"Huysentruyt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristel","family":"van de Maele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luana","family":"Nosetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Agosti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Salvatoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1862-8651","authenticated-orcid":false,"given":"Yvan","family":"Vandenplas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,9,4]]},"reference":[{"issue":"3","key":"314_CR1","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1097\/MPG.0000000000001889","volume":"66","author":"R Rosen","year":"2018","unstructured":"Rosen R, Vandenplas Y, Singendonk M, et al. Pediatric gastroesophageal reflux clinical practice guidelines: joint recommendations of the north american society for pediatric gastroenterology, hepatology, and nutrition and the European society for pediatric gastroenterology, hepatology, and nutrition. J Pediatr Gastroenterol Nutr. 2018;66(3):516\u201354.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"314_CR2","doi-asserted-by":"publisher","unstructured":"Tighe M, Afzal NA, Bevan A, et al. Pharmacological treatment of children with gastro-oesophageal reflux. Cochrane Database Syst Rev. 2014;(11):CD008550. https:\/\/doi.org\/10.1002\/14651858.CD008550.pub2 .","DOI":"10.1002\/14651858.CD008550.pub2"},{"key":"314_CR3","unstructured":"National Institute for Health and Care Excellence (NICE). Gastro-oesophageal reflux disease: recognition, diagnosis and management in children and young people. (Clinical Guideline 193) 2015. http:\/\/www.nice.org.uk\/guidance\/NG1 ."},{"issue":"7","key":"314_CR4","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1111\/j.2042-7158.1997.tb06085.x","volume":"49","author":"FA Johnson","year":"1997","unstructured":"Johnson FA, Craig DQ, Mercer AD. Characterization of the block structure and molecular weight of sodium alginates. J Pharm Pharmacol. 1997;49(7):639\u201343.","journal-title":"J Pharm Pharmacol"},{"issue":"6","key":"314_CR5","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1111\/j.1365-2036.1990.tb00509.x","volume":"4","author":"JR Lambert","year":"1990","unstructured":"Lambert JR, Korman MG, Nicholson L, et al. In-vivo antireflux and raft properties of alginates. Aliment Pharmacol Ther. 1990;4(6):615\u201322.","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"314_CR6","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/j.2042-7158.1990.tb05348.x","volume":"42","author":"N Washington","year":"1990","unstructured":"Washington N, Greaves JL, Wilson CG. Effect of time of dosing relative to a meal on the raft formation of an anti-reflux agent. J Pharm Pharmacol. 1990;42(1):50\u20133.","journal-title":"J Pharm Pharmacol"},{"issue":"1","key":"314_CR7","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1080\/03639045.2017.1371737","volume":"44","author":"PW Dettmar","year":"2018","unstructured":"Dettmar PW, Gil-Gonzalez D, Fisher J, et al. A comparative study on the raft chemical properties of various alginate antacid raft-forming products. Drug Dev Ind Pharm. 2018;44(1):30\u20139.","journal-title":"Drug Dev Ind Pharm"},{"issue":"6","key":"314_CR8","doi-asserted-by":"publisher","first-page":"949-954.e2","DOI":"10.1016\/j.jpeds.2010.07.029","volume":"157","author":"Silvia Salvatore","year":"2010","unstructured":"Salvatore S, Arrigo S, Luini C, et al. Esophageal impedance in children: symptom-based results. J Pediatr. 2010;157(6):949-54.e1-2.","journal-title":"The Journal of Pediatrics"},{"issue":"4","key":"314_CR9","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1097\/01.mpg.0000361306.15727.54","volume":"49","author":"Y Vandenplas","year":"2009","unstructured":"Vandenplas Y, Rudolph CD, Di Lorenzo C, et al. Pediatric gastroesophageal reflux clinical practice guidelines: joint recommendations of the North American society for pediatric gastroenterology, hepatology, and nutrition (NASPGHAN) and the European society for pediatric gastroenterology, hepatology, and nutrition (ESPGHAN). J Pediatr Gastroenterol Nutr. 2009;49(4):498\u2013547.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"3","key":"314_CR10","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1097\/MPG.0b013e318216940e","volume":"53","author":"D Pilic","year":"2011","unstructured":"Pilic D, H\u00f6fs C, Weitmann S, et al. Inter- and intraobserver agreement in 24-hour combined multiple intraluminal impedance and pH measurement in children. J Pediatr Gastroenterol Nutr. 2011;53(3):255\u20139.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"3","key":"314_CR11","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.pcl.2017.01.003","volume":"64","author":"H Mousa","year":"2017","unstructured":"Mousa H, Hassan M. Gastroesophageal reflux disease. Pediatr Clin North Am. 2017;64(3):487\u2013505.","journal-title":"Pediatr Clin North Am"},{"issue":"4","key":"314_CR12","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1097\/MPG.0b013e3181f474c7","volume":"52","author":"TI Omari","year":"2011","unstructured":"Omari TI, Schwarzer A, van Wijk MP, et al. Optimisation of the reflux-symptom association statistics for use in infants being investigated by 24-hour pH impedance. J Pediatr Gastroenterol Nutr. 2011;52(4):408\u201313.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"4","key":"314_CR13","first-page":"358","volume":"83","author":"GJ Wiener","year":"1988","unstructured":"Wiener GJ, Richter JE, Copper JB, et al. The symptom index: a clinically important parameter of ambulatory 24-hour esophageal pH monitoring. Am J Gastroenterol. 1988;83(4):358\u201361.","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"314_CR14","first-page":"160","volume":"86","author":"R Breumelhof","year":"1991","unstructured":"Breumelhof R, Smout AJ. The symptom sensitivity index: a valuable additional parameter in 24-hour esophageal pH recording. Am J Gastroenterol. 1991;86(2):160\u20134.","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"314_CR15","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1007\/BF02090215","volume":"39","author":"HG Lam","year":"1994","unstructured":"Lam HG, Breumelhof R, Roelofs JM, et al. What is the optimal time window in symptom analysis of 24-hour esophageal pressure and pH data? Dig Dis Sci. 1994;39(2):402\u20139.","journal-title":"Dig Dis Sci"},{"issue":"2","key":"314_CR16","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1097\/MPG.0000000000000521","volume":"60","author":"D Ummarino","year":"2015","unstructured":"Ummarino D, Miele E, Martinelli M, et al. Effect of magnesium alginate plus simethicone on gastroesophageal reflux in infants. J Pediatr Gastroenterol Nutr. 2015;60(2):230\u20135.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"4","key":"314_CR17","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1111\/j.1365-2036.2010.04545.x","volume":"33","author":"L Corvaglia","year":"2011","unstructured":"Corvaglia L, Aceti A, Mariani E, et al. The efficacy of sodium alginate (Gaviscon) for treatment of gastroesophageal reflux in preterm infants. Aliment Pharmacol Ther. 2011;33(4):466\u201370.","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"314_CR18","doi-asserted-by":"publisher","first-page":"476-481.e1","DOI":"10.1016\/j.jpeds.2012.03.002","volume":"161","author":"Osvaldo Borrelli","year":"2012","unstructured":"Borrelli O, Mancini V, Thapar N, et al. Cow\u2019s milk challenge increases weakly acidic reflux in children with cow\u2019s milk allergy and gastroesophageal reflux disease. J Pediatr 2012;161(3):476-81.e1.","journal-title":"The Journal of Pediatrics"},{"issue":"2","key":"314_CR19","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1007\/BF02343223","volume":"146","author":"JP Buts","year":"1986","unstructured":"Buts JP, Barudi C, Otte JB. Double-blind controller study on the efficacy of sodium alginate (Gaviscon) in reducing gastroesophageal reflux assessed by 24 h continuous pH monitoring in infants and children. Eur J Pediatr. 1986;146(2):156\u20138.","journal-title":"Eur J Pediatr"},{"issue":"3","key":"314_CR20","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1185\/03007999909114087","volume":"15","author":"S Miller","year":"1999","unstructured":"Miller S. Comparison of the efficacy and safety of a new aluminum-free pediatric alginate preparation and placebo in infants with recurrent gastro-oesophageal reflux. Curr Med Res Opin. 1999;15(3):160\u20138.","journal-title":"Curr Med Res Opin"},{"issue":"12","key":"314_CR21","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.earlhumdev.2011.05.013","volume":"87","author":"L Corvaglia","year":"2011","unstructured":"Corvaglia L, Spizzichino M, Zama D, et al. Sodium Alginate (Gaviscon\u00ae) does not reduce apnoeas related to gastro-oesophageal reflux in preterm infants. Early Hum Dev. 2011;87(12):775\u20138.","journal-title":"Early Hum Dev."},{"issue":"5","key":"314_CR22","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1136\/adc.2002.024463","volume":"90","author":"R Buono Del","year":"2005","unstructured":"Del Buono R, Wenzl TG, Ball G, et al. Effect of Gaviscon Infant on gastro-oesophageal reflux in infants assessed by combined intraluminal impedance\/pH. Arch Dis Child. 2005;90(5):460\u20133.","journal-title":"Arch Dis Child"},{"key":"314_CR23","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/S0378-5173(98)00143-4","volume":"170","author":"FA Johnson","year":"1998","unstructured":"Johnson FA, Craig DQ, Mercer A, et al. The use of image analysis as a means of monitoring bubble formation in alginate rafts. Int J Pharmaceut. 1998;170:179\u201385.","journal-title":"Int J Pharmaceut."},{"issue":"4","key":"314_CR24","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1055\/s-2007-1010479","volume":"24","author":"G Bertoni","year":"1992","unstructured":"Bertoni G, Gumina C, Conigliaro R, et al. Randomized placebo-controlled trial of oral liquid simethicone prior to upper gastrointestinal endoscopy. Endoscopy. 1992;24(4):268\u201370.","journal-title":"Endoscopy."},{"issue":"6","key":"314_CR25","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1046\/j.1365-2036.2000.00759.x","volume":"14","author":"KG Mandel","year":"2000","unstructured":"Mandel KG, Daggy BP, Brodie DA, et al. Review article: alginate-raft formulations in the treatment of heartburn and acid reflux. Aliment Pharmacol Ther. 2000;14(6):669\u201390.","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"314_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/dote\/dow020","volume":"30","author":"DA Leiman","year":"2017","unstructured":"Leiman DA, Riff BP, Morgan S, et al. Alginate therapy is effective treatment for GERD symptoms: a systematic review and meta-analysis. Dis Esophagus. 2017;30(5):1\u20139.","journal-title":"Dis Esophagus"},{"issue":"9","key":"314_CR27","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1111\/apt.12482","volume":"38","author":"CT Chiu","year":"2013","unstructured":"Chiu CT, Hsu CM, Wang CC, et al. Randomised clinical trial: sodium alginate oral suspension is non-inferior to omeprazole in the treatment of patients with non-erosive gastroesophageal disease. Aliment Pharmacol Ther. 2013;38(9):1054\u201364.","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"314_CR28","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/apt.12857","volume":"40","author":"A Ruigh De","year":"2014","unstructured":"De Ruigh A, Roman S, Chen J, et al. Gaviscon double action liquid (antacid & alginate) is more effective than antacid in controlling post-prandial oesophageal acid exposure in GERD patients: a double-blind crossover study. Aliment Pharmacol Ther. 2014;40(5):531\u20137.","journal-title":"Aliment Pharmacol Ther"},{"issue":"8","key":"314_CR29","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1023\/A:1024703504585","volume":"48","author":"RG Nielsen","year":"2003","unstructured":"Nielsen RG, Kruse-Andersen S, Husby S. Low reproducibility of 2 \u00d7 24-hour continuous esophageal pH monitoring in infants and children: a limiting factor for interventional studies. Dig Dis Sci. 2003;48(8):1495\u2013502.","journal-title":"Dig Dis Sci"},{"issue":"4","key":"314_CR30","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1136\/gut.31.4.374","volume":"31","author":"Y Vandenplas","year":"1990","unstructured":"Vandenplas Y, Helven R, Goyvaerts H, et al. Reproducibility of continuous 24 hour oesophageal pH monitoring in infants and children. Gut. 1990;31(4):374\u20137.","journal-title":"Gut"},{"issue":"10","key":"314_CR31","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1111\/j.1365-2036.2005.02677.x","volume":"22","author":"F. ZERBIB","year":"2005","unstructured":"Zerbib F, des Varannes SB, Roman S, et al. Normal values and day-to-day variability of 24-h ambulatory oesophageal impedance-pH monitoring in a Belgian-French cohort of healthy subjects. Aliment Pharmacol Ther. 2005;22(10):1011\u201321.","journal-title":"Alimentary Pharmacology and Therapeutics"}],"container-title":["Pediatric Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40272-018-0314-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-018-0314-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-018-0314-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T22:28:52Z","timestamp":1720564132000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40272-018-0314-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,4]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["314"],"URL":"https:\/\/doi.org\/10.1007\/s40272-018-0314-0","relation":{},"ISSN":["1174-5878","1179-2019"],"issn-type":[{"value":"1174-5878","type":"print"},{"value":"1179-2019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,4]]},"assertion":[{"value":"4 September 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"SS has participated as a consultant and\/or speaker for Danone-Nutricia, Deca, IMS-Health, Menarini, and Nestle. YV has participated as a clinical investigator, and\/or advisory board member, and\/or consultant, and\/or speaker for Abbott Nutrition, Biocodex, Danone, Nestle Health Science, Nestle Nutrition Institute, Nutricia, Mead Johnson, and United Pharmaceuticals. None of the above manufacturers and companies have had any input or involvement in any aspect of this study. The other authors have no conflicts of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"No funding or other support was given for this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}}]}}